27 June 2022 - AGM trading update
The AIM-listed developer and manufacturer of medical instruments mainly used in minimally invasive surgery has announced a trading update to coincide with its AGM today. The company has stated that following a strong final quarter to 2021, trading has continued to be strong in 2022 with revenues for the period showing significant growth, and these are expected to be 22% ahead of the same period in 2021. The group expects this trend to continue in the second half so that full year results should meet expectations. Trading in the UK remains strong due . . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.